We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

2d31

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="2d31" size="450" color="white" frame="true" align="right" spinBox="true" caption="2d31, resolution 3.20&Aring;" /> '''Crystal structure o...)
Line 1: Line 1:
-
[[Image:2d31.gif|left|200px]]<br />
+
[[Image:2d31.gif|left|200px]]<br /><applet load="2d31" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="2d31" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="2d31, resolution 3.20&Aring;" />
caption="2d31, resolution 3.20&Aring;" />
'''Crystal structure of disulfide-linked HLA-G dimer'''<br />
'''Crystal structure of disulfide-linked HLA-G dimer'''<br />
==Overview==
==Overview==
-
HLA-G is a nonclassical major histocompatibility complex class I (MHCI), molecule, which is expressed in trophoblasts and confers immunological, tolerance in the maternal-fetal interface by binding to leukocyte Ig-like, receptors (LILRs, also called as LIR/ILT/CD85) and CD8. HLA-G is expressed, in disulfide-linked dimer form both in solution and at the cell surface., Interestingly, MHCI dimer formations have been involved in pathogenesis, and T cell activation. The structure and receptor binding characteristics, of MHCI dimers have never been evaluated. Here we performed binding, studies showing that the HLA-G dimer exhibited higher overall affinity to, LILRB1/2 than the monomer by significant avidity effects. Furthermore, the, cell reporter assay demonstrated that the dimer formation remarkably, enhanced the LILRB1-mediated signaling at the cellular level. We further, determined the crystal structure of the wild-type dimer of HLA-G with the, intermolecular Cys(42)-Cys(42) disulfide bond. This dimer structure showed, the oblique configuration to expose two LILR/CD8-binding sites upward from, the membrane easily accessible for receptors, providing plausible 1:2, (HLA-G dimer:receptors) complex models. These results indicated that the, HLA-G dimer conferred increased avidity in a proper structural orientation, to induce efficient LILR signaling, resulting in the dominant, immunosuppressive effects. Moreover, structural and functional, implications for other MHCI dimers observed in activated T cells and the, pathogenic allele, HLA-B27, are discussed.
+
HLA-G is a nonclassical major histocompatibility complex class I (MHCI) molecule, which is expressed in trophoblasts and confers immunological tolerance in the maternal-fetal interface by binding to leukocyte Ig-like receptors (LILRs, also called as LIR/ILT/CD85) and CD8. HLA-G is expressed in disulfide-linked dimer form both in solution and at the cell surface. Interestingly, MHCI dimer formations have been involved in pathogenesis and T cell activation. The structure and receptor binding characteristics of MHCI dimers have never been evaluated. Here we performed binding studies showing that the HLA-G dimer exhibited higher overall affinity to LILRB1/2 than the monomer by significant avidity effects. Furthermore, the cell reporter assay demonstrated that the dimer formation remarkably enhanced the LILRB1-mediated signaling at the cellular level. We further determined the crystal structure of the wild-type dimer of HLA-G with the intermolecular Cys(42)-Cys(42) disulfide bond. This dimer structure showed the oblique configuration to expose two LILR/CD8-binding sites upward from the membrane easily accessible for receptors, providing plausible 1:2 (HLA-G dimer:receptors) complex models. These results indicated that the HLA-G dimer conferred increased avidity in a proper structural orientation to induce efficient LILR signaling, resulting in the dominant immunosuppressive effects. Moreover, structural and functional implications for other MHCI dimers observed in activated T cells and the pathogenic allele, HLA-B27, are discussed.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
2D31 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2D31 OCA].
+
2D31 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2D31 OCA].
==Reference==
==Reference==
Line 29: Line 28:
[[Category: mhc class i]]
[[Category: mhc class i]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 21:25:45 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:54:51 2008''

Revision as of 14:54, 21 February 2008


2d31, resolution 3.20Å

Drag the structure with the mouse to rotate

Crystal structure of disulfide-linked HLA-G dimer

Contents

Overview

HLA-G is a nonclassical major histocompatibility complex class I (MHCI) molecule, which is expressed in trophoblasts and confers immunological tolerance in the maternal-fetal interface by binding to leukocyte Ig-like receptors (LILRs, also called as LIR/ILT/CD85) and CD8. HLA-G is expressed in disulfide-linked dimer form both in solution and at the cell surface. Interestingly, MHCI dimer formations have been involved in pathogenesis and T cell activation. The structure and receptor binding characteristics of MHCI dimers have never been evaluated. Here we performed binding studies showing that the HLA-G dimer exhibited higher overall affinity to LILRB1/2 than the monomer by significant avidity effects. Furthermore, the cell reporter assay demonstrated that the dimer formation remarkably enhanced the LILRB1-mediated signaling at the cellular level. We further determined the crystal structure of the wild-type dimer of HLA-G with the intermolecular Cys(42)-Cys(42) disulfide bond. This dimer structure showed the oblique configuration to expose two LILR/CD8-binding sites upward from the membrane easily accessible for receptors, providing plausible 1:2 (HLA-G dimer:receptors) complex models. These results indicated that the HLA-G dimer conferred increased avidity in a proper structural orientation to induce efficient LILR signaling, resulting in the dominant immunosuppressive effects. Moreover, structural and functional implications for other MHCI dimers observed in activated T cells and the pathogenic allele, HLA-B27, are discussed.

Disease

Known diseases associated with this structure: Asthma, susceptibility to OMIM:[142871], Hypoproteinemia, hypercatabolic OMIM:[109700]

About this Structure

2D31 is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer., Shiroishi M, Kuroki K, Ose T, Rasubala L, Shiratori I, Arase H, Tsumoto K, Kumagai I, Kohda D, Maenaka K, J Biol Chem. 2006 Apr 14;281(15):10439-47. Epub 2006 Feb 2. PMID:16455647

Page seeded by OCA on Thu Feb 21 16:54:51 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools